Bio-Thera Solutions announces positive top-line results for BAT1706, a proposed biosimilar to Avastin

Bio-Thera Solutions announces positive top-line results for BAT1706, a proposed biosimilar to Avastin

Submitted by admin on February 4, 2020 - 10:05am
Source: 
Pharmaceutical Business Review
News Tags: 
BAT1706
Bio-Thera Solutions
Avastin
Roche
non-squamous non-small cell lung cancer
biosimilars
Headline: 
Bio-Thera Solutions announces positive top-line results for BAT1706, a proposed biosimilar to Avastin
snippet: 

BAT1706 is being developed by Bio-Thera Solutions as a proposed biosimilar to Avastin. The trial demonstrated equivalence in overall response rate (ORR) for the first-line treatment of patients

Do Not Allow Advertisers to Use My Personal information